1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Kaposi Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukunaga, A; Khaskhely, NM; Masaki, T; Nishigori, C; Ono, R; Sreevidya, CS; Ullrich, SE | 1 |
| Al-Hassani, M; Harrison, KA; Konger, RL; Murphy, RC; Rezania, S; Travers, JB; Yao, Y | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Kaposi Disease
| Article | Year |
|---|---|
Agents that reverse UV-Induced immune suppression and photocarcinogenesis affect DNA repair.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Deoxyguanosine; DNA Repair; Immune Tolerance; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Oxidative Stress; Piperazines; Platelet Activating Factor; Reactive Oxygen Species; Serotonin Antagonists; Skin Neoplasms; Ultraviolet Rays; Urocanic Acid; Xeroderma Pigmentosum; Xeroderma Pigmentosum Group A Protein | 2010 |
Platelet-activating factor receptor agonists mediate xeroderma pigmentosum A photosensitivity.
Topics: Animals; Antioxidants; Humans; Mice; Mice, Inbred C57BL; Mice, Knockout; Phosphorylcholine; Platelet Activating Factor; Platelet Membrane Glycoproteins; Radiation Tolerance; Reactive Oxygen Species; Receptors, G-Protein-Coupled; Skin; Tumor Necrosis Factor-alpha; Ultraviolet Rays; Xeroderma Pigmentosum; Xeroderma Pigmentosum Group A Protein | 2012 |